3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
23
Burkitt Lymphoma
19
Lymphoma, Large B-Cell, Diffuse
17
Multiple Myeloma
15
Lymphoma, Non-Hodgkin
13
Lymphoma, Follicular
11
Lymphoma
11
Leukemia, Myeloid, Acute
11
Recurrence
10
Ovarian Neoplasms
9
Lymphoma, B-Cell
9
Myelodysplastic Syndromes
8
Pancreatic Neoplasms
7
Leukemia, Lymphocytic, Chronic, B-Cell
7
Leukemia
7
Lymphoma, Mantle-Cell
6
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
6
Hodgkin Disease
6
Hematologic Neoplasms
6
Breast Neoplasms
6
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
5
Neoplasms
5
Leukemia, Myelomonocytic, Chronic
5
Triple Negative Breast Neoplasms
4
Stomach Neoplasms
4
Sarcoma, Ewing
4
Sarcoma
4
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
4
Osteosarcoma
4
Lymphoma, Large-Cell, Anaplastic
4
Interventions
Oxaliplatin
7
Fluorouracil
7
Paclitaxel
5
Leucovorin
5
pembrolizumab
4
Trastuzumab
4
Radiation
4
Capecitabine
4
tislelizumab
3
Taxes
3
Specimen Handling
3
Nivolumab
3
Carboplatin
3
ulixertinib
2
trastuzumab biosimilar HLX02
2
patritumab deruxtecan
2
Surgical Procedures, Operative
2
Radiotherapy
2
Pemetrexed
2
PF-05280014
2
Ontruzant
2
Ogivri
2
Irinotecan
2
Exercise
2
Docetaxel
2
Cisplatin
2
CT-P6
2
zolbetuximab
1
zimberelimab
1
zanidatamab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Esophageal Neoplasms
×
Cyclophosphamide
×
30 days
×
Clear all
No trials found.